Goldman Sachs Maintains Buy on Waters, Raises Price Target to $515

9/21/2026
Impact: 75
Healthcare

Goldman Sachs analyst Evie Koslosky has reaffirmed a Buy rating on Waters Corporation (NYSE: WAT) and increased the price target from $465 to $515. This adjustment reflects a positive outlook for the company's performance in the market.

AI summary, not financial advice

Share: